{"version":"1.0","type":"rich","provider_name":"NULLPEN","provider_url":"https://nullpen.com","title":"Trial results posted: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia (\"PRO-SID\" Study)","cache_age":300,"width":400,"height":320,"html":"<iframe src=\"https://nullpen.com/embed?story=sha256%3Abd3621c2bd45771552cc78c8126b9e9c379d3dd2d04ae6287457a46671b6925c\" title=\"Trial results posted: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia (&quot;PRO-SID&quot; Study)\" width=\"400\" height=\"320\" loading=\"lazy\" style=\"border:0;max-width:100%\" referrerpolicy=\"strict-origin-when-cross-origin\" sandbox=\"allow-popups allow-popups-to-escape-sandbox\"></iframe>"}